JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 9.60
0.00 (0.00%)
At close: Apr 16, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 316.76 million as of April 16, 2026. Its market cap has decreased by -61.05% in one year.
Market Cap
316.76M
Enterprise Value
406.88M
Revenue
744.78M
Ranking
n/a
PE Ratio
11.99
Stock Price
9.60
Market Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 316.76M, a decrease of -56.69%. That is a compound annual growth rate of -20.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 316.76M | -23.20% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mangalam Drugs & Organics | 480.07M |
| Vista Pharmaceuticals | 465.95M |
| Panjon | 429.11M |
| Welcure Drugs and Pharmaceuticals | 420.22M |
| Walpar Nutritions | 396.75M |
| Sandu Pharmaceuticals | 367.02M |
| Murae Organisor | 353.20M |
| ANG Lifesciences India | 324.11M |